Coordinatore | EUROPEAN ORGANIZATION FOR NUCLEAR RESEARCH
Organization address
address: ROUTE DE MEYRIN CERN contact info |
Nazionalità Coordinatore | Switzerland [CH] |
Totale costo | 240˙482 € |
EC contributo | 240˙482 € |
Programma | FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) |
Code Call | FP7-PEOPLE-2009-IEF |
Funding Scheme | MC-IEF |
Anno di inizio | 2011 |
Periodo (anno-mese-giorno) | 2011-07-01 - 2013-06-30 |
# | ||||
---|---|---|---|---|
1 |
EUROPEAN ORGANIZATION FOR NUCLEAR RESEARCH
Organization address
address: ROUTE DE MEYRIN CERN contact info |
CH (GENEVA 23) | coordinator | 240˙482.40 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'I intend to search for new long-lived elementary particles decaying to tau leptons in the CMS Experiment tracker volume. To accomplish this I will extend the capabilities of the current state-of-the-art detection systems for charged particle “tracking” to enable the inclusion of significantly displaced tau. Initiating such a search gives me the understanding of any limitations in the current system’s capabilities, and thus the insight for how to modify the tracking detectors to enable and enhance future searches. I plan also to contribute to the construction of the new tracking detectors by connecting this work, and CERN in general, to efforts I am leading in the UK to create a highly inter- and multidisciplinary centre of excellence in the area of detector systems.'
Scientists searched for long-lived elementary particles that decay into tau leptons at the European Organization for Nuclear Research (CERN).
"Educational, Scientific and Technological Aspects of Mesoscopic Continuum Physics for Waves in Complex Materials"
Read MoreTrait diversity: assemblage of communities and their feedbacks to Ecosystem Multifunctionality
Read MorePrevention of zoonotic tissue cyst formation in sheep using live attenuated and parapoxvirus vector based vaccines against Toxoplasma gondii
Read More